Interleukin-6 Family Cytokines

10.1073/pnas.84.18.6434

2015, The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity, Cytokine Growth Factor Rev, 26, 579, 10.1016/j.cytogfr.2015.07.008

10.1038/75068

10.1073/pnas.98.4.1757

10.1097/CCM.0b013e318211ff56

10.1016/0167-5699(90)90139-Z

10.1126/science.1631562

10.1126/science.1083901

1987, Molecular cloning and expression of hybridoma growth factor in Escherichia coli, J Immunol, 139, 4116, 10.4049/jimmunol.139.12.4116

1990, Structure–function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants, J Immunol, 145, 561, 10.4049/jimmunol.145.2.561

10.1681/ASN.2014111147

10.1158/0008-5472.CAN-15-2388

10.1038/nrrheum.2014.127

10.1182/blood-2007-01-067918

10.1126/science.1058308

10.1126/science.274.5291.1379

10.1126/science.7681218

10.1016/0092-8674(95)90172-8

10.4049/jimmunol.1600019

10.1038/ni1084

10.1172/JCI200522433

10.1016/j.cytogfr.2015.07.013

10.1038/78765

10.1016/j.tig.2003.11.003

10.1038/clpt.2010.1

10.1371/journal.pgen.1003444

10.1038/nbt0297-142

10.1016/S0140-6736(13)60250-0

10.1096/fj.99-0913com

10.1038/nrd4624

10.1016/j.cytogfr.2012.04.001

10.1074/jbc.M112.432955

2014, The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases, Biochim Biophys Acta, 1842, 1485, 10.1016/j.bbadis.2014.05.018

10.1073/pnas.84.20.7251

1987, Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF), EMBO J, 6, 3995, 10.1002/j.1460-2075.1987.tb02742.x

1991, Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130, EMBO J, 10, 2839, 10.1002/j.1460-2075.1991.tb07833.x

10.1126/science.1542794

10.4049/jimmunol.1002971

10.1016/j.ccr.2009.01.001

1986, Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts, Eur J Biochem, 159, 625, 10.1111/j.1432-1033.1986.tb09931.x

10.1016/j.cytogfr.2015.07.006

10.1016/0092-8674(90)90411-7

10.1038/324073a0

1989, Molecular cloning of the cDNAs for interleukin-6/B cell stimulatory factor 2 and its receptor, Ann NY Acad Sci, 557, 167, 10.1111/j.1749-6632.1989.tb24010.x

10.4049/jimmunol.1201044

10.1634/stemcells.22-4-522

10.1016/S0167-4889(02)00319-1

10.1172/JCI57158

10.1046/j.1432-1327.2001.01867.x

10.1053/j.gastro.2003.10.066

2013, Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis, Mol Genet Genomic Med, 1, 223, 10.1002/mgg3.28

1999, Novel path to activation of vascular smooth muscle cells: Up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor, J Immunol, 163, 4583, 10.4049/jimmunol.163.8.4583

10.1038/368339a0

10.1016/j.cmet.2015.02.006

1997, Lethal tuberculosis in interleukin-6-deficient mutant mice, Infect Immun, 65, 4843, 10.1128/IAI.65.11.4843-4849.1997

10.1016/j.ccr.2011.03.009

10.1038/nrm909

10.1126/science.2587985

10.1158/0008-5472.CAN-10-1496

2016, Proteolytic cleavage governs interleukin-11 trans-signaling, Cell Rep, 14, 1761, 10.1016/j.celrep.2016.01.053

10.1681/ASN.2014060620

10.1016/j.str.2010.10.010

10.1016/1043-4666(92)90043-Q

10.1126/science.8272872

1992, Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins, J Immunol, 149, 2021, 10.4049/jimmunol.149.6.2021

10.1128/MCB.9.7.2847

2002, Differential response of neuronal cells to a fusion protein of ciliary neurotrophic factor/soluble CNTF-receptor and leukemia inhibitory factor, Eur J Biochem, 269, 3023, 10.1046/j.1432-1033.2002.02977.x

10.1038/365027a0

10.4049/jimmunol.0801217

10.1007/s00125-010-1865-y

10.1136/gut.2005.079343

10.1074/jbc.272.31.19625

10.4049/jimmunol.173.3.1681

10.1074/jbc.271.51.32635

10.1016/0006-291X(92)92272-Y

10.1002/eji.1830230226

1994, The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site, J Immunol, 152, 4958, 10.4049/jimmunol.152.10.4958

10.4049/jimmunol.164.9.4672

1997, Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis, Blood, 90, 2148, 10.1182/blood.V90.6.2148

2000, Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody therapy, Blood, 95, 56, 10.1182/blood.V95.1.56

10.4049/jimmunol.171.6.3202

10.4049/jimmunol.182.1.613

10.1093/intimm/dxh396

1997, Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman’s disease, Am J Pathol, 151, 1517

10.1073/pnas.87.19.7512

10.1073/pnas.92.4.1142

10.1016/S0896-6273(00)80281-0

10.1053/gast.2000.20236

10.1016/S0014-5793(99)00477-9

10.4049/jimmunol.172.4.2225

10.1182/blood-2007-07-102137

10.1038/nature07475

10.1002/art.21818

10.1038/nm0398-303

2015, The soluble interleukin-6 receptor and related proteins, Best Pract Res Clin Endocrinol Metab, 29, 787, 10.1016/j.beem.2015.07.001

10.1042/bj3000281

10.1016/j.cytogfr.2015.07.011

10.1073/pnas.0509598103

10.1164/rccm.201512-2368OC

10.1016/j.cytogfr.2015.07.004

10.1016/j.it.2011.05.005

10.1016/j.jhep.2016.02.004

10.1161/ATVBAHA.111.229435

10.1074/jbc.M115.649509

10.1074/jbc.M210044200

10.1517/14740338.2015.993605

2012, Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosis, Immunobiology, 217, 996, 10.1016/j.imbio.2012.01.015

10.1146/annurev-immunol-032713-120211

10.1101/cshperspect.a028555

10.1038/359076a0

10.1038/342920a0

10.1016/j.ejcb.2010.10.016

10.1182/blood-2011-09-377705

10.1016/0092-8674(89)90438-8

10.1016/j.smim.2014.01.009

The New York Academy of Sciences Conference. 1988. Regulation of the acute phase and immune responses: Interleukin-6 (ed. Sehgal PB , Grieninger G , Tosato G ). The New York Academy of Sciences, New York.

2013, Interleukin-6 trans-signaling exacerbates inflammation and renal pathology in lupus-prone mice, Arthritis Rheum, 65, 2691, 10.1002/art.38061

10.1634/stemcells.20-2-119

10.1038/nri1901

10.1210/jc.2012-3462

10.1016/j.cmet.2010.06.011

10.1126/science.3136546

10.1101/cshperspect.a028530

10.1182/blood-2011-03-340885

10.1172/JCI64931

1986, Structure and expression of cDNA and genes for human interferon-β-2, a distinct species inducible by growth-stimulatory cytokines, EMBO J, 5, 2529, 10.1002/j.1460-2075.1986.tb04531.x